Stay updated on HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision from v3.5.3 to v3.5.4 on the page indicates a minor platform/update change. It reflects an underlying system or interface update rather than any modification to the study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-05-15T23:19:48.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page’s footer “Revision” indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change rather than new or changed study information.
    Difference
    0.1%
    Check dated 2026-04-24T16:48:17.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T13:32:30.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T19:13:11.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T15:00:58.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    Administrative updates include adding Revision: v3.4.2 and removing a government funding status notice as well as Revision: v3.4.1; these changes do not affect the study details, eligibility criteria, or results information.
    Difference
    0.4%
    Check dated 2026-02-11T20:35:39.000Z thumbnail image

Stay in the know with updates to HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HBI-8000 Combo with Nivolumab in Solid Tumors Clinical Trial page.